Update on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Other Guidance Documents
Published
June 1, 2024
Last updated
June 1, 2024
Description
Document provides an update on guidelines for assessing the presence of harmful phthalates in medical devices, focusing on carcinogenic, mutagenic, reproductive toxic, and endocrine-disrupting properties. Topics include other guidance documents.
Tags
Organization
Country / Region
European Union
License
Creative Commons Attribution 4.0